Ilsung Pharmaceuticals Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top 16 shareholders own 92.61% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
46.5%	Seok-geun Yoon	3,243,555	₩64.4b	0%	no data
16.9%	Pine Tree Investment & Management Co., Ltd, Asset Management Arm	1,177,180	₩23.4b	0%	100.0%
10.1%	Sugsan D & P Inc.	703,960	₩14.0b	0%	no data
8.05%	Daejeong Scholarship Committee, Endowment Arm	560,875	₩11.1b	0%	no data
7.92%	Deok-Geun Yoon	551,970	₩11.0b	0%	no data
1.83%	Dimensional Fund Advisors LP	127,314	₩2.5b	8.18%	no data
0.43%	Jong-Ho Yun	30,060	₩596.7m	0%	no data
0.42%	Jong-Uk Yun	29,335	₩582.3m	0%	no data
0.28%	Jae-Seung Yoon	19,175	₩380.6m	0%	no data
0.049%	Samsung Asset Management Company, Ltd.	3,387	₩67.2m	-13.5%	no data
0.04%	KB Asset Management Co., Ltd.	2,791	₩55.4m	46.1%	no data
0.034%	Hanwha Asset Management Co. Ltd.	2,390	₩47.4m	0%	no data
0.017%	AXA Investment Managers S.A.	1,200	₩23.8m	0%	no data
0.014%	Mirae Asset Global Investments Co., Ltd.	944	₩18.7m	-36.2%	no data
0.00072%	Korea Investment Management Co., Ltd.	50	₩996.0k	-28.6%	no data
0.00062%	Daishin Investment Trust Management Co., Ltd.	43	₩857.7k	0%	no data